Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Cardiac Allograft Vasculopathy
NCT02472002Phase 2Suspended
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2014
- Primary completion
- Jan 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in cardiac allograft vasculopathy (CAV), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2014; status: suspended.
02
Drugs
mesenchymal stem cells
03
Conditions
cardiac allograft vasculopathy (CAV)
Beyond the preview
Go deeper on NCT02472002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02472002.